From our latest issue...
- Beyond ‘simple’ biology – turning organoids, spheroids, and 3D tissue models into physiologically relevant high-content assays for drug discovery
- New frontiers in G protein-coupled receptor drug discovery
- Proteomics: cracking the molecular mystery of diseases and therapeutics
- Webinar highlights: Integrated fragment based approach reveals enzymatic inhibitors with potential therapeutic application
- Omics-informed drug target discovery in combating emerging infectious diseases